This invention relates to 3-[1-thiazolidinylbutyl-4-piperazinyl]-1H-indazoles of the formula ##STR1## where R.sub.1 and R.sub.2 are each independently hydrogen or loweralkyl or R.sub.1 and R.sub.2 taken together with the carbon atom to which they are attached form a cyclopentane, cyclohexane or cycloheptane ring; R.sub.3 and R.sub.4 are independently hydrogen or loweralkyl or R.sub.3 and R.sub.4 taken together with the carbon atom to which they are attached form a cyclopentane, cyclohexane or cycloheptane ring; R.sub.5 is hydrogen, loweralkyl, alkanoyl or aroyl; X is hydrogen, halogen, loweralkyl or alkoxy; m is an integer of 1 to 3, the pharmaceutically acceptable acid addition salts thereof and where applicable, the optical, geometrical and stereoisomers and racemic mixtures thereof. The compounds of this invention are useful as antipsychotic agents.
该发明涉及式的3-[1-
噻唑烷基-4-
哌嗪基]-1H-
吲唑醇 ##STR1##,其中R.sub.1和R.sub.2分别独立地为氢或低烷基,或R.sub.1和R.sub.2与它们连接的碳原子一起形成
环戊烷、
环己烷或
环庚烷环;R.sub.3和R.sub.4独立地为氢或低烷基,或R.sub.3和R.sub.4与它们连接的碳原子一起形成
环戊烷、
环己烷或
环庚烷环;R.sub.5为氢、低烷基、烷酰基或芳酰基;X为氢、卤素、低烷基或烷氧基;m为1到3的整数,其药学上可接受的酸盐及必要时的光学、几何和立体异构体和混合物。该发明的化合物可用作
抗精神病药物。